Baidu
map

内分泌科指南

订阅

MedSci主页 / 所有栏目 / 内分泌科指南

2016 ATA指南：甲状腺功能亢进症和其他原因导致的甲状腺功能亢进的诊断和管理

2016-08-12 美国甲状腺协会 Thyroid. 2016 Aug 12.

甲状腺功能亢进症

2016年8月，美国甲状腺协会(ATA)发布了甲状腺功能亢进症和其他原因导致的甲状腺功能亢进的诊断和管理指南，甲状腺功能亢进有多种病因，临床表现以及潜在治疗方法，本文针对甲状腺功能亢进的诊断和管理等内容共提出了124条推荐意见。

中文标题：

2016 ATA指南：甲状腺功能亢进症和其他原因导致的甲状腺功能亢进的诊断和管理

英文标题：

2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and other causes of Thyrotoxicosis.

发布机构：

美国甲状腺协会

发布日期：

2016-08-12

简要介绍：

2016年8月，美国甲状腺协会(ATA)发布了甲状腺功能亢进症和其他原因导致的甲状腺功能亢进的诊断和管理指南，甲状腺功能亢进有多种病因，临床表现以及潜在治疗方法，本文针对甲状腺功能亢进的诊断和管理等内容共提出了124条推荐意见。


相关资料下载：
[AttachmentFileName(sort=100, fileName=2016 ATA指南：甲状腺功能亢进症和其他原因导致的甲状腺功能亢进的诊断和管理)] GetToolGuiderByIdResponse(projectId=1, id=a41ec1c001256262, title=2016 ATA指南：甲状腺功能亢进症和其他原因导致的甲状腺功能亢进的诊断和管理, enTitle=2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and other causes of Thyrotoxicosis., guiderFrom=Thyroid. 2016 Aug 12., authorId=null, author=, summary=2016年8月，美国甲状腺协会(ATA)发布了甲状腺功能亢进症和其他原因导致的甲状腺功能亢进的诊断和管理指南，甲状腺功能亢进有多种病因，临床表现以及潜在治疗方法，本文针对甲状腺功能亢进的诊断和管理等内容共提出了124条推荐意见。, cover=, journalId=null, articlesId=null, associationId=131, associationName=美国甲状腺协会, associationIntro=内容涉及甲状腺基础与临床研究 ,包括细胞生物学、碘代谢、自身免疫、信号转导、肿瘤发生、基因治疗、流行病学诸方面的内容。, copyright=0, guiderPublishedTime=Fri Aug 12 00:00:00 CST 2016, originalUrl=, linkOutUrl=, content=<div>2016年8月，美国甲状腺协会(ATA)发布了甲状腺功能亢进症和其他原因导致的甲状腺功能亢进的诊断和管理指南，甲状腺功能亢进有多种病因，临床表现以及潜在治疗方法，本文针对甲状腺功能亢进的诊断和管理等内容共提出了124条推荐意见。</div> <div><br> 拓展指南：<strong>与<font color="red">甲状腺功能亢进</font>相关指南：</strong><br><ul><li><a href="//www.sandwebs.com/guideline/show_article.do?id=2d6751c00093e8e4" title="2012 ETA促甲状腺素受体突变导致的家族性以及持续性、散发性、非自身免疫性甲状腺功能亢进的诊治指南" target="_blank">2012 ETA促甲状腺素受体突变导致的家族性以及持续性、散发性、非自身免疫性甲状腺功能亢进的诊治指南</a></li> 更多信息请点击：<a href="//www.sandwebs.com/guideline/list.do?q=%E7%94%B2%E7%8A%B6%E8%85%BA%E5%8A%9F%E8%83%BD%E4%BA%A2%E8%BF%9B" target="_blank">有关甲状腺功能亢进更多指南</a></ul></div><div><br></div><div><br></div>, tagList=[TagDto(tagId=12478, tagName=甲状腺功能亢进症)], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌科, tenant=100), CategoryDto(categoryId=73, categoryName=头颈外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=1, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=11381, appHits=950, showAppHits=15, pcHits=8447, showPcHits=3174, likes=194, shares=51, comments=3, approvalStatus=1, publishedTime=Thu Aug 18 10:48:13 CST 2016, publishedTimeString=2016-08-12, pcVisible=1, appVisible=1, editorId=5295957, editor=lili, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=lili, createdTime=Thu Aug 18 10:48:13 CST 2016, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 09:16:10 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2016 ATA指南：甲状腺功能亢进症和其他原因导致的甲状腺功能亢进的诊断和管理)])
2016 ATA指南：甲状腺功能亢进症和其他原因导致的甲状腺功能亢进的诊断和管理
下载请点击：
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2100232, encodeId=300b210023272, content=继续学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fed68428547, createdName=ms4000001036881415, createdTime=Sun Nov 13 09:36:36 CST 2022, time=2022-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=101339, encodeId=0275101339f1, content=继续学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Aug 20 13:24:00 CST 2016, time=2016-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=101340, encodeId=49a01013408f, content=继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Aug 20 13:24:00 CST 2016, time=2016-08-20, status=1, ipAttribution=)]
    2022-11-13 ms4000001036881415

    继续学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2100232, encodeId=300b210023272, content=继续学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fed68428547, createdName=ms4000001036881415, createdTime=Sun Nov 13 09:36:36 CST 2022, time=2022-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=101339, encodeId=0275101339f1, content=继续学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Aug 20 13:24:00 CST 2016, time=2016-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=101340, encodeId=49a01013408f, content=继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Aug 20 13:24:00 CST 2016, time=2016-08-20, status=1, ipAttribution=)]
    2016-08-20 doctorJiangchao

    继续学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2100232, encodeId=300b210023272, content=继续学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fed68428547, createdName=ms4000001036881415, createdTime=Sun Nov 13 09:36:36 CST 2022, time=2022-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=101339, encodeId=0275101339f1, content=继续学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Aug 20 13:24:00 CST 2016, time=2016-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=101340, encodeId=49a01013408f, content=继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Sat Aug 20 13:24:00 CST 2016, time=2016-08-20, status=1, ipAttribution=)]
    2016-08-20 doctorJiangchao

    继续关注

    0

Baidu
map
Baidu
map
Baidu
map